UnitedHealth Group (UNH) released updates on its 2022 annual shareholder meeting and actions by its Board of Directors. The Shareholders elected all those nominated to the Board; Timothy P. Flynn, Paul R. Garcia, Stephen J. Hemsley, Michele J. Hooper, F. William McNabb III, Valerie C. Montgomery Rice, M.D., John H. Noseworthy, M.D., and Andrew Witty.
Stockholders also approved
- The resolution on the Company’s executive compensation.
- Authorized Deloitte & Touche LLP as the Company’s independent registered public accounting firm.
- Voted against the stockholder proposal seeking shareholder approval of termination pay, and against the shareholder proposal regarding a political contributions congruency report.
The board also announced a cash dividend of $1.65 per share payable June 28, 2022, to common stock shareholders as of June 20, 2022.
If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.